Taught course

Cancer Pharmacology

London Metropolitan University · School of Human Sciences

Entry requirements

The normal academic standard for entry is: A Lower Second (2.2) UK first degree in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics. These will be considered on an individual basis. Equivalent overseas qualifications will also be accepted.

Months of entry

January, September

Course content

Course overview

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of this course are to:

  • provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving;
  • review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease;
  • enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data;
  • deliver a programme of advanced study to equip you for a future career in anti-cancer drug development.

Course structure

The MSc is a one year, full-time course involving 30 weeks of taught modules divided into two 15-week semesters. The part-time mode follows a similar pattern over two years. You take five core modules, one optional module plus a research project.

Core modules:

  • Molecular Oncology
  • Cancer Pharmacology
  • Cancer: Diagnosis & Treatment
  • Molecular Genetics
  • Scientific Frameworks for Research
  • Research Project

Optional modules:

  • Drug Discovery Technology
  • Advanced Drug Formulation Technologies
  • Bioinformatics and Molecular Modelling

Career opportunities

This course is primarily designed for those wishing to pursue a career in anti-cancer drug development, whether in academia or within the pharmaceutical industry. The programme provides an excellent basis for further research or study.

Information for international students

All applicants must be able to demonstrate proficiency in the English language. Applicants who require a Tier 4 student visa may need to provide a Secure English Language Test (SELT) such as Academic IELTS. For more information about English qualifications please see our English language requirements.

Fees and funding

UK students
£7,965 per year
International students
£11,700 per year

Qualification and course duration


full time
12 months
part time
24 months

Course contact details

Admissions Office
020 7133 4202